This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
What the researchers found
Different protein delivery vehicles (cell-penetrating peptides, bacterial toxins, injection systems) showed widely varying ability to deliver cargo into erythroid precursor cells. Targeting cell surface receptors improved some vehicles but not others.
Why it matters
Red blood cell precursors are notoriously hard to deliver drugs into. This systematic comparison identifies the best strategies for this challenging cell type, important for treating blood diseases like sickle cell and thalassemia.
The numbers in context
Multiple CPPs, CPP additives, bacterial toxins, and contractile injection systems evaluated. Delivery to HUDEP-2 and CD34+ cells. Some vehicles benefited from receptor targeting; others did not.
How the study worked
Evaluated cell-penetrating peptides, CPP additives, bacterial toxins, and contractile injection systems for cargo delivery to HUDEP-2 erythroid progenitor cells and primary CD34+ hematopoietic stem cells. Tested receptor-mediated targeting strategies.
Who was studied
HUDEP-2 erythroid progenitor cells and primary CD34+ hematopoietic stem cells
What this study cannot tell us
In vitro study. Cell line results may not reflect primary cell behavior in vivo. No animal testing. Delivery efficiency for therapeutic payloads not directly measured for all vehicles.
Read the original research
Engineering Cell-Specific Protein Delivery Vehicles for Erythroid Lineage Cells.
ACS bio & med chem Au, 5(2), 268-282
Citation
Setegne, Mekedlawit T; Cabral, Aidan T; Tiwari, Anushri; Shen, Fangfang; Thiam, Hawa Racine; Dassama, Laura M K. (2025). Engineering Cell-Specific Protein Delivery Vehicles for Erythroid Lineage Cells.. ACS bio & med chem Au, 5(2), 268-282. https://doi.org/10.1021/acsbiomedchemau.4c00098